Alterity Therapeutics Limited American Depositary Shares (ATHE)

Price$5.15

Favorite Metrics

Price vs S&P 500 (26W)-25.41%

Price vs S&P 500 (4W)33.36%

Market Capitalization$77.97M

All Metrics

Book Value / Share (Quarterly)$0.00

P/TBV (Annual)2.72x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)463.07%

Cash Flow / Share (Quarterly)$-0.00

Price vs S&P 500 (YTD)20.86%

Net Profit Margin (TTM)-1172.16%

EPS (TTM)$-0.00

10-Day Avg Trading Volume4.25M

EPS Excl Extra (TTM)$-0.00

Revenue Growth (5Y)91.97%

EPS (Annual)$-0.00

ROI (Annual)-36.10%

Net Profit Margin (5Y Avg)-136347.96%

Cash / Share (Quarterly)$0.00

Revenue Growth QoQ (YoY)717.39%

ROA (Last FY)-31.06%

Revenue Growth TTM (YoY)376.33%

EBITD / Share (TTM)$-0.00

ROE (5Y Avg)-80.12%

Operating Margin (TTM)-1337.31%

Cash Flow / Share (Annual)$-0.00

P/B Ratio2.00x

P/B Ratio (Quarterly)1.60x

Net Income / Employee (Annual)$-1

EV / Revenue (TTM)47.92x

Net Interest Coverage (TTM)-179.00x

ROA (TTM)-28.35%

EPS Incl Extra (Annual)$-0.00

Current Ratio (Annual)7.07x

Quick Ratio (Quarterly)21.98x

3-Month Avg Trading Volume6.19M

52-Week Price Return25.00%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.11

P/S Ratio (Annual)243.69x

Asset Turnover (Annual)0.00x

52-Week High$0.02

Operating Margin (5Y Avg)-162219.75%

EPS Excl Extra (Annual)$-0.00

Tangible BV CAGR (5Y)5.72%

26-Week Price Return-16.67%

Quick Ratio (Annual)6.79x

13-Week Price Return17.65%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)21.98x

Enterprise Value$42.766

Asset Turnover (TTM)0.02x

Book Value / Share Growth (5Y)-19.83%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-2706.71%

Cash / Share (Annual)$0.01

3-Month Return Std Dev137.47%

Net Income / Employee (TTM)$-1

ROE (Last FY)-36.22%

Net Interest Coverage (Annual)-509.65x

EPS Basic Excl Extra (Annual)$-0.00

Receivables Turnover (TTM)26.83x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.00

Receivables Turnover (Annual)17.24x

ROI (TTM)-30.11%

P/S Ratio (TTM)87.37x

Pretax Margin (5Y Avg)-135654.32%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.05

Price vs S&P 500 (52W)-10.09%

Year-to-Date Return25.00%

5-Day Price Return11.11%

EPS Normalized (Annual)$-0.00

ROA (5Y Avg)-63.71%

Net Profit Margin (Annual)-2721.96%

Month-to-Date Return11.11%

Cash Flow / Share (TTM)$-0.00

EBITD / Share (Annual)$-0.00

Operating Margin (Annual)-3185.21%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-79.89%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.00

P/TBV (Quarterly)1.00x

P/B Ratio (Annual)0.88x

Pretax Margin (TTM)-1161.75%

Book Value / Share (Annual)$0.01

Price vs S&P 500 (13W)14.78%

Beta1.34x

Revenue / Share (TTM)$0.00

ROE (TTM)-30.19%

52-Week Low$0.01

About

Alterity Therapeutics is a clinical-stage biotechnology company developing novel treatments for Parkinson's disease and other neurodegenerative disorders. The company's proprietary pipeline targets the underlying pathology of these diseases through compounds designed to bind excess iron, reduce alpha-synuclein aggregation, and restore neuronal function. Lead programs include ATH434 and related candidates, supported by a broader drug discovery platform.